We are live on ! Find out more
PAMS

Pictet Asset Management (Switzerland) Portfolio holdings

AUM $84.3B
1-Year Est. Return 26.5%
This Fund
S&P 500
This Quarter Est. Return
-7.4%
1 Year Est. Return
+26.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$88.3B
AUM Growth
-$12.2B
Cap. Flow
-$2.67B
Cap. Flow %
-3.02%
Top 10 Hldgs %
13.86%
Holding
1,779
New
62
Increased
704
Reduced
424
Closed
99

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$285M
2
AMD icon
Advanced Micro Devices
AMD
+$179M
3
WM icon
Waste Management
WM
+$158M
4
TSLA icon
Tesla
TSLA
+$142M
5
GEN icon
Gen Digital
GEN
+$137M

Top Sells

Rank Stock Value
1
ADSK icon
Autodesk
ADSK
+$355M
2
XLNX
Xilinx Inc
XLNX
+$329M
3
NXPI icon
NXP Semiconductors
NXPI
+$315M
4
BIDU icon
Baidu
BIDU
+$298M
5
AAPL icon
Apple
AAPL
+$274M

Sector Composition

Rank Sector Weight
1 Technology 27.8%
2 Healthcare 15.1%
3 Industrials 14.13%
4 Utilities 9.83%
5 Consumer Discretionary 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNGO icon
1651
Bionano Genomics
BNGO
$13.8M
$52K ﹤0.01%
34
EXK
1652
Endeavour Silver
EXK
$3.14B
$52K ﹤0.01%
11,100
HLX icon
1653
Helix Energy Solutions
HLX
$1.49B
$52K ﹤0.01%
10,800
GERN icon
1654
Geron
GERN
$1.01B
$51K ﹤0.01%
37,400
GEVO icon
1655
Gevo
GEVO
$391M
$51K ﹤0.01%
10,824
GOTU icon
1656
Gaotu Techedu
GOTU
$410M
$51K ﹤0.01%
29,500
LOGC
1657
DELISTED
ContextLogic
LOGC
$50K ﹤0.01%
739
CRON
1658
Cronos Group
CRON
$1.17B
$48K ﹤0.01%
12,300
AMRS
1659
DELISTED
Amyris Inc.
AMRS
$48K ﹤0.01%
11,100
ATRS
1660
DELISTED
Antares Pharma, Inc.
ATRS
$46K ﹤0.01%
11,300
SRNE
1661
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$44K ﹤0.01%
19,066
HIPO icon
1662
Hippo Holdings
HIPO
$868M
$43K ﹤0.01%
857
UXIN
1663
Uxin Ltd
UXIN
$249M
$42K ﹤0.01%
411
SENS icon
1664
Senseonics Holdings Inc
SENS
$419M
$41K ﹤0.01%
1,048
BTBT icon
1665
Bit Digital
BTBT
$509M
$37K ﹤0.01%
10,400
DOYU
1666
DouYu International Holdings
DOYU
$138M
$35K ﹤0.01%
1,660
AGEN
1667
Agenus
AGEN
$311M
$31K ﹤0.01%
632
IDEX
1668
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$31K ﹤0.01%
218
IVR icon
1669
Invesco Mortgage Capital
IVR
$802M
$30K ﹤0.01%
1,304
DFTX
1670
Definium Therapeutics
DFTX
$5.75B
$30K ﹤0.01%
1,831
SOS
1671
SOS Limited
SOS
$16.1M
$28K ﹤0.01%
70
MUX icon
1672
McEwen Inc
MUX
$1.18B
$23K ﹤0.01%
2,730
OCFT
1673
DELISTED
OneConnect Financial Technology
OCFT
$23K ﹤0.01%
1,600
CLVS
1674
DELISTED
Clovis Oncology, Inc.
CLVS
$22K ﹤0.01%
10,800
VBIV
1675
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$19K ﹤0.01%
391

Similar funds

Pictet Asset Management (Switzerland)'s Q1 2022 Portfolio in Review

As of Q1 2022, Pictet Asset Management (Switzerland) held 1,779 positions worth $88.3B, down 12% from $100B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Pictet Asset Management (Switzerland) withdrew a net $2.67B in Q1 2022, closing 99 positions and reducing 424 holdings. Its most notable exit was Xilinx Inc, an estimated $329M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Pictet Asset Management (Switzerland) opened a new position in Constellation Energy worth $67.1M.

  • Pictet Asset Management (Switzerland)'s largest Q1 2022 buy was Constellation Energy: 1,192,329 shares worth $67.1M.
  • Pictet Asset Management (Switzerland) added most to Salesforce in Q1 2022, an estimated $285M increase.
  • Pictet Asset Management (Switzerland)'s biggest Q1 2022 reduction was Autodesk, cutting an estimated $355M.
  • Pictet Asset Management (Switzerland) fully exited Xilinx Inc in Q1 2022, selling an estimated $329M.
  • Pictet Asset Management (Switzerland)'s ten largest holdings make up 14% of its $88.3B portfolio in Q1 2022.
  • Pictet Asset Management (Switzerland) opened 62 new positions and closed 99 in Q1 2022.
  • Pictet Asset Management (Switzerland)'s portfolio value fell 12% quarter-over-quarter to $88.3B.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q1 2022, filed 13 May 2022.